Argenx
ARGX
#638
Rank
C$43.23 B
Marketcap
$722.96
Share price
-0.62%
Change (1 day)
4.41%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Operating Margin for Argenx (ARGX)

Operating Margin as of September 2024 (TTM): -177.55%

According to Argenx 's latest financial reports and stock price the company's current Operating Margin is -177.55%. At the end of 2022 the company had an Operating Margin of -177.56%.

Operating Margin history for Argenx from 2013 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2022-177.56%120.88%
2021-80.39%-94.52%
2020-1,467.77%554.64%
2019-224.21%-26.85%
2018-306.52%306.2%
2017-75.46%-48.06%
2016-145.27%-34.97%
2015-223.40%-18.64%
2014-274.60%19.9%
2013-229.03%-61.01%
2012-587.40%90.71%
2011-308.00%

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.